( (NASDAQ: FBRX), a clinical-stage biopharmaceutical company focused on autoimmune and autoimmune-related diseases, today announced positive results from the FB102 double-blind placebo-controlled ...

Abstract: When the soft-switching three-phase inverter is applied in transformerless photovoltaic (PV) systems, its common-mode (CM) leakage current has to be suppressed to satisfy grid codes. However ...

Insilico Medicine ("Insilico," HKEX: 3696), a clinical-stage biotechnology company powered by generative AI, today announced the initiation of the Phase III clinical trial for Rentosertib, its ...

Globally recognized leader in early-phase oncology clinical development and experimental therapeuticsStrengthens strategic ...

A newly found chain-reaction phase change in 2D MoTe2 lowers energy barriers, enabling faster control of electronic and ...

Phase transformations—in which a material changes from one crystal structure to another, thereby acquiring dramatically ...

New Preclinical Data Demonstrate Favorable Oral Bioavailability, Robust Brain Penetration and Liver Exposure with Once-Daily ...

A deep reinforcement learning framework optimizes silicon-based photonic crystal fiber modulators, achieving ultra-low ...

Quantum materials, materials exhibiting physical behavior governed by the laws of quantum mechanics, have proved promising ...

Otsuka Pharmaceutical Development & Commercialization, Inc. and Otsuka Pharmaceutical Co., Ltd. (Otsuka) today announced positive topline full study results from the Phase 3 VISIONARY trial. VOYXACT ® ...

The development of the 6G standard is entering a more concrete phase. At the June 2026 3GPP RAN Plenary in Singapore, the industry advanced several key areas under study and finalized the timeline for ...

Bupropion conferred modest reductions in cancer-related fatigue compared with placebo, according to results of a randomized ...